A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients

Terri G. Thompson, Christine J. Didonato, Louise R. Simard, Susan E. Ingraham, Arthur H.M. Burghes, Thomas O. Crawford, Camille Rochette, Jerry R. Mendell, John J. Wasmuth

Research output: Contribution to journalArticlepeer-review

Abstract

Spinal muscular atrophy (SMA) is the second most common lethal, autosomal recessive disease in Caucasians (after cystic fibrosis). Childhood SMAs are divided into three groups (type I, II and III), which are allelic variants of the same locus in a region of ∼850 kb in chromosome 5q12–q13, containing multiple copies of a novel, chromosome 5–specific repeat as well as many atypical pseudogenes. This has hampered the identification of candidate genes. We have identified several coding sequences unique to the SMA region. A genomic fragment detected by one cDNA is homozygously deleted in 17/29 (58%) of type I SMA patients. Of 235 unaffected individuals examined, only two showed the deletion and both are carriers of SMA. Our results suggest that deletion of at least part of this novel gene is directly related to the phenotype of SMA.

Original languageEnglish (US)
Pages (from-to)56-62
Number of pages7
JournalNature genetics
Volume9
Issue number1
DOIs
StatePublished - Jan 1995

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients'. Together they form a unique fingerprint.

Cite this